Yimeng Lu
- Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 studyBy Edward Kerwin, Jacques Hébert, Nicola Gallagher, Carmen Martin, Tim Overend, Vijay K.T. Alagappan, Yimeng Lu and Donald BanerjiEdward Kerwin*Clinical Research Institute of Southern Oregon, PC, Medford, ORJacques Hébert#Centre de Recherche Appliquée en Allergie de Québec, Québec, QC, CanadaNicola Gallagher¶Novartis Horsham Research Centre, Horsham, UKCarmen Martin¶Novartis Horsham Research Centre, Horsham, UKTim Overend¶Novartis Horsham Research Centre, Horsham, UKVijay K.T. Alagappan+Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAYimeng Lu+Novartis Pharmaceuticals Corporation, East Hanover, NJ, USADonald Banerji+Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.